Exemed Pharmaceuticals to buy UCB Indian production facility
The deal, which is in line with UCB’s strategy on bringing new drugs to patients and less on mass manufacturing, includes a multi-year supply agreement between both the
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.
Multi-centre, randomized trial designed to compare C3BS-CQR-1 treatment with sham treatment is expected to enroll at least 240 patients suffering from chronic advanced symptomatic heart failure. The composite
The efflux transporter knockout cell lines identify individual drug-transporter interactions, which is a component to understand the safety and efficacy characteristics of drug candidates. Sigma Life Science market